Morepen Laboratories Limited has informed the Exchange regarding Notice of 40th Annual General Meeting to be held on September 06, 2025
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Morepen Laboratories has called its 40th AGM on Saturday, September 6, 2025, at 1:00 PM to be held via video conferencing. Shareholders on record as of August 30, 2025 will be eligible to vote and receive the declared final dividend of Rs. 0.20 per equity share (face value Rs. 2) for FY 2024-25. Key agenda items include adopting FY25 financial statements, re-appointing Mr. Sanjay Suri as Whole-Time Director for three years (pay package up to Rs. 7 crore per year including commissions), re-appointing Mrs. (Dr.) Savita as Independent Director for a second five-year term, and ratifying the appointment of Cost Auditors and a new Secretarial Auditor for five years (FY26–FY30). The company is also seeking shareholder approval to extend the deadline for hiving off its Medical Devices business into subsidiary Morepen Medipath Limited until the FY26 AGM, and to enable conversion of lender loans into equity if needed. Two relatives of senior directors will also receive salaries up to Rs. 60 lakh each per year starting October 1, 2025, subject to member approval.
Routine AGM agenda with a modest final dividend (Rs. 0.20/share) and standard re-appointments. The proposed loan-to-equity conversion clause and extension of the Medical Devices hive-off are worth noting as they could affect future shareholding and capital structure if triggered.